Literature DB >> 29017983

Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.

Jung Hee Kim1, Jung Hyun Lee2, Ji Hyun Lee3, A Ram Hong3, Yoon Ji Kim4, Yong Hwy Kim5.   

Abstract

OBJECTIVE: The outcomes of recent endoscopic surgery of nonfunctioning pituitary adenomas (NFPAs) are controversial when compared with traditional microscopic surgery. We aimed to assess the outcomes of endoscopic transsphenoidal surgeries performed by 1 surgeon with 7 years of experience and elucidate the predictive factors for surgical outcomes for NFPAs.
METHODS: We included 331 patients (155 men and 176 women) with clinical NFPAs who underwent transsphenoidal surgery because of visual symptoms by a single surgeon in Seoul National University Hospital from March 2010 to May 2016. We assessed the tumor removal rate, hormonal outcomes, visual outcomes, and complications.
RESULTS: The gross total resection rate of endoscopic transsphenoidal surgery for NFPAs by a single surgeon was 74.9%. Cavernous sinus invasion, a high Knosp grade, large tumor size, previous surgery, and lack of surgical experience in the neurosurgeon elevated the risk for residual tumors. Visual deficits were improved in 73.4% of the patients, which was associated with tumor size, preoperative visual impairment score, previous radiation, and surgical experience. Hormonal status was improved in 15.4% and aggravated in 32.9% after surgery. There were no predictors for hormonal recovery. Transient diabetes insipidus (DI) was the most common complication (9.1%), and among these patients, 3.0% had persistent DI.
CONCLUSIONS: Endoscopic transsphenoidal surgery by a well-experienced surgeon was an effective and safe treatment for NFPAs, but the hormonal outcomes were not changed compared with previous reports of microscopic surgery. Large tumor size and cavernous sinus invasion were still the barriers for achieving total resection.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopic transsphenoidal surgery; Gross total resection; Hormone deficiency; Nonfunctioning pituitary adenoma; Visual deficit

Mesh:

Year:  2017        PMID: 29017983     DOI: 10.1016/j.wneu.2017.09.194

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  17 in total

Review 1.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

Review 2.  The experience with transsphenoidal surgery and its importance to outcomes.

Authors:  Jürgen Honegger; Florian Grimm
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

3.  Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas: results from a 26-year experience.

Authors:  Jinxiu Yu; Yanli Li; Tingting Quan; Xi Li; Chao Peng; Jiamin Zeng; Shunyao Liang; Minyi Huang; Yong He; Yinhui Deng
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

4.  The role of E and N-cadherin in the postoperative course of gonadotroph pituitary tumours.

Authors:  Kristin Astrid Berland Øystese; Jens Petter Berg; Kjersti Ringvoll Normann; Manuela Zucknick; Olivera Casar-Borota; Jens Bollerslev
Journal:  Endocrine       Date:  2018-07-26       Impact factor: 3.633

5.  Role of pituitary stalk and gland radiological status on endocrine function and outcome after endoscopic transsphenoidal surgery for non-functioning pituitary adenomas.

Authors:  C Vivancos Sánchez; A Palpán Flores; V Rodríguez Domínguez; A Zamarrón Pérez; C Álvarez-Escolá; C Pérez López
Journal:  Endocrine       Date:  2021-04-20       Impact factor: 3.633

6.  Endoscopic vs. microscopic transsphenoidal surgery outcomes in 514 nonfunctioning pituitary adenoma cases.

Authors:  Shuaihua Song; Linping Wang; Qianjin Qi; Haoran Wang; Li Feng
Journal:  Neurosurg Rev       Date:  2022-03-01       Impact factor: 3.042

7.  The impact of endoscopic transsphenoidal pituitary adenoma surgery on endocrine function: a single-centre study.

Authors:  Luke Galloway; Mohamed Ali; Andrew Lansdown; Peter Taylor; Aled Rees; John Stephen Davies; Caroline Hayhurst
Journal:  Acta Neurochir (Wien)       Date:  2020-10-21       Impact factor: 2.216

8.  Safety of endoscopic endonasal biopsy for the pituitary stalk-hypothalamic lesions.

Authors:  Ho Kang; Kyung-Min Kim; Min-Sung Kim; Jung Hee Kim; Chul-Kee Park; Yong Hwy Kim
Journal:  Pituitary       Date:  2021-09-01       Impact factor: 4.107

9.  Visual Outcomes after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas: Our Institutional Experience.

Authors:  Max J van Essen; Ivo S Muskens; Nayan Lamba; Stephan F J Belunek; Arthur T J van der Boog; G Johan Amelink; Peter H Gosselaar; Tristan P C van Doormaal; Aline M E Stades; Joost J C Verhoeff; Maria M van Genderen; Christine A E Eenhorst; Marike L D Broekman
Journal:  J Neurol Surg B Skull Base       Date:  2020-02-03

10.  Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients.

Authors:  Jai Deep Thakur; Alex Corlin; Regin Jay Mallari; Samantha Yawitz; Amalia Eisenberg; Walavan Sivakumar; Chester Griffiths; Ricardo L Carrau; Sarah Rettinger; Pejman Cohan; Howard Krauss; Katherine A Araque; Garni Barkhoudarian; Daniel F Kelly
Journal:  Pituitary       Date:  2021-07-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.